“…There are an estimated 153,760 new cases each year in the United States and over 50,000 patients died from this disease in 2007 (39) . In recent years, clinical, histopathologic, molecular and genetic variables have been identified that are associated with CRC patient survival (1,3,9,10,14,15,20,24,37,39,45) . These include early diagnosis (37) , age (3) , neoplastic site (46) , degree of histological differentiation (14) deep wall intestinal invasion, (10) lymph node invasion (1,9) , mucus production (15) , carcinoembryonic antigen (CEA) serum levels (24) angiolymphatic invasion (21) and genomic expression profiles (45) .…”